Veterinary Safety Notice | This article is for informational and educational purposes only and does not constitute veterinary advice. Cats metabolize compounds very differently from dogs and humans — always consult a licensed veterinarian before giving CBD or any supplement to your cat. Never give cats products containing THC, essential oils (especially tea tree, peppermint, citrus, eucalyptus), propylene glycol, or other feline-toxic ingredients. CBD is not FDA-approved for veterinary use. Individual results may vary.
Cats are not small dogs. This is the single most important principle in feline veterinary medicine — and it's directly relevant to CBD. Cats have a fundamentally different metabolic system that makes them highly vulnerable to compounds that dogs and humans tolerate without difficulty. Essential oils, certain carrier compounds, and numerous medications that are safe for dogs are toxic or even lethal for cats.
CBD itself — the cannabidiol molecule — appears reasonably tolerated by cats based on available evidence. The safety problem is almost always with the other ingredients in CBD products: essential oil flavorings that are toxic to cats, propylene glycol that cats cannot metabolize, xylitol sweeteners, and MCT or coconut-derived carriers that may cause GI upset in feline systems.
This guide covers why cats require a uniquely cautious approach, what the limited research shows, what conditions CBD may help with in cats, and exactly what ingredients to look for and avoid. For the broader pet CBD foundation, readCBD for Dogs: What the Research Shows — many of the ECS principles apply to cats as well.
The most important metabolic difference between cats and other mammals — the one that makes cats susceptible to toxicity from compounds that dogs and humans handle easily — is glucuronidation deficiency.
Glucuronidation is a major liver detoxification pathway — one of the primary ways the body neutralizes and prepares compounds for excretion. It involves enzymes called UDP-glucuronosyltransferases (UGTs) that attach a glucuronic acid molecule to drugs, toxins, and metabolites, making them water-soluble for renal excretion.
Cats are obligate carnivores — in nature, they eat exclusively meat. Plant compounds that require glucuronidation for detoxification (phenols, terpenes, many plant-derived molecules) were rarely encountered in their evolutionary diet. As a result, cats evolved without needing robust glucuronidation capacity — they lack functional UGT1A6 and UGT1A9 enzymes, the ones specifically responsible for processing many plant-derived phenolic compounds. A2013 review in Veterinary Journal established this glucuronidation deficiency as the primary driver of drug and toxin sensitivity in cats.
CBD itself is metabolized primarily through CYP450 pathways rather than exclusively through glucuronidation — which is why CBD appears more tolerable for cats than many other plant compounds. However, many ingredients commonly found in CBD products do require glucuronidation — and these are the ones that cause problems:
|
Factor |
Dogs |
Cats |
Implication for CBD |
|
Glucuronidation (drug metabolism pathway) |
Normal capacity — processes many drugs efficiently |
SEVERELY DEFICIENT — cats lack UGT1A6 and UGT1A9 enzymes for glucuronidation |
Cats cannot process many compounds that dogs and humans tolerate — much higher toxicity risk from most drugs |
|
CBD metabolism |
CYP450 metabolism — similar to humans; reasonable half-life |
CYP450 metabolism present but slower overall; glucuronidation limitation affects clearance |
CBD itself appears reasonably tolerated; CBD products with other ingredients are the concern |
|
Essential oil sensitivity |
Can tolerate small amounts of many essential oils |
Most essential oils are TOXIC — lack enzymes to metabolize phenols and terpenes |
Human CBD products flavored with essential oils (peppermint, citrus, lavender) are dangerous for cats |
|
THC toxicity |
Highly toxic — neurological symptoms at low doses |
Also highly toxic — potentially more severe than dogs |
Verified zero-THC mandatory — even stricter concern than dogs |
|
Body size |
5–150+ lbs variation; dose scales widely |
Typically 6–14 lbs for adult cats; less variation |
Smaller body size means errors in measurement have larger proportional effect |
|
Oral palatability |
Most dogs will accept oil on food or directly |
Cats are highly selective — many refuse oils; delivery can be challenging |
Cat-specific formulations with appropriate palatability are important |
|
ECS expression |
CB1/CB2 receptors throughout CNS, joints, GI, immune tissue |
CB1/CB2 receptors present — similar distribution to dogs and humans |
Same ECS-based mechanisms apply; similar therapeutic targets |
The honest picture: feline-specific CBD research is significantly less developed than canine research. There are no published RCTs examining CBD for any condition specifically in cats — unlike dogs, where three academic RCTs exist.
The most directly relevant published research on CBD in cats is pharmacokinetic — examining how cats absorb and process CBD. A2021 study in the Journal of Feline Medicine and Surgery examined CBD bioavailability in cats given CBD oil versus CBD-infused treats. Key findings: cats showed measurable CBD absorption with both forms; oral bioavailability was lower in cats than typically reported in dogs; and no serious adverse events were observed. The most common adverse effects were head shaking and lip-licking — likely related to the oil's taste — rather than signs of toxicity.
A2021 survey in the Journal of the American Holistic Veterinary Medical Association examining CBD use in cats found that among cat owners using CBD, the most common applications were anxiety and pain, with the majority reporting at least some improvement in their cats' condition. No serious adverse events were commonly reported in this owner survey. However, owner surveys are subject to significant reporting bias and placebo effects.
Given the absence of feline RCTs, most veterinary guidance on CBD for cats extrapolates from the canine research — acknowledging that the ECS mechanisms are similar across mammals while being cautious about species-specific metabolic differences. This extrapolation supports the plausibility of CBDfor similar conditions in cats, but should be held more tentatively than the dog evidence given the species differences.
|
Condition |
CBD's Potential Role |
Evidence Level |
Vet Involvement Required? |
|
Anxiety (vet visits, travel, new environments) |
5-HT1A anxiolytic; HPA cortisol modulation — same mechanisms as humans and dogs; cats have robust serotonin system |
Limited direct feline RCTs; strong mechanistic rationale; owner survey data generally positive |
Recommended before starting; required for severe anxiety |
|
Chronic pain (arthritis, dental, post-surgical) |
CB2 anti-inflammatory; TRPV1 analgesia; ECS modulation — same pathways as dogs and humans |
Limited direct feline RCTs; dog pain evidence extrapolates to cats (same CB2 mechanisms) |
Yes — pain diagnosis and management requires veterinary assessment |
|
Inflammatory conditions (IBD, skin, joint) |
CB2-mediated cytokine suppression; ECS modulation — well-established mechanism |
Preclinical data; growing observational evidence; mechanism strong |
Yes — IBD in cats requires diagnosis and ongoing management |
|
Seizures / epilepsy |
CBD's anti-seizure mechanism established across species; CB1 modulation of neural excitability |
Very limited feline-specific data; dog seizure RCT results extrapolate mechanistically |
Always — seizure management is complex in cats and requires specialist care |
|
Appetite stimulation (especially in illness) |
CB1 in appetite regulation; nausea reduction; ECS appetite modulation |
Mechanism-based; some owner reports positive in illness contexts |
Yes — reduced appetite in cats often indicates underlying illness requiring diagnosis |
|
Cancer palliative care (pain, nausea, comfort) |
Pain relief; nausea reduction; appetite support — symptom management only |
Mechanism-based; commonly used in palliative settings |
Yes — oncology team oversight; CBD not a cancer treatment |
Important:There is no published RCT dose for cats the way there is for dogs (Cornell's 2mg/kg for OA). The following guidance is based on pharmacokinetic data, veterinary consensus, and extrapolation — treat it as a starting framework, not a precise evidence-based recommendation.
Frequency:The 2021 pharmacokinetic study suggested CBD's half-lifein cats may be shorter than in dogs — possibly necessitating twice-daily dosing for consistent therapeutic coverage, though this is an area requiring more research.
Cats are notoriously selective about what they eat and how. The taste and texture of CBD oil is often a significant barrier:
What not to use for delivery:Peanut butter is often recommended for dogs — do not use for cats, as some formulations contain xylitol. Do not mix into dairy products — most cats are lactose intolerant. Do not use any food that could mask signs the cat isn't consuming the full dose.

CBD itself — without THC, essential oils, or other feline-toxic ingredients — appears reasonably safe for cats based on available pharmacokinetic studies and owner survey data. The primary safety risks come from other ingredients in CBD products, not from CBD itself. Any CBD product given to cats must be verified free of THC, essential oils, propylene glycol, and xylitol. Veterinary consultation before starting is strongly recommended.
Only if the product has been verified free of essential oils, propylene glycol, xylitol, and THC — and if you can accurately measure the very small feline doses from the oil's concentration. Many dog CBD products contain ingredients that are harmful to cats. Verify the full ingredient list against feline safety criteria before giving any dog CBD product to a cat. Cat-specific formulations are significantly safer.
CBD's anxiolytic mechanisms — 5-HT1A serotonin receptor activation, HPA cortisol modulation — are active in cats as in dogs and humans. Owner surveys suggest many cat owners report anxiety improvement. The evidence base is much thinner than for dogs, and severe anxiety in cats (hiding, aggression, inappropriate elimination) should be evaluated by a veterinarian or veterinary behaviorist rather than managed solely with supplements.
The CB2 anti-inflammatory and TRPV1 analgesic mechanisms that work in dogs apply to cats through the same ECS pathways. No feline arthritis RCT exists, but the mechanism extrapolation from the dog OA evidence is reasonable. Cats are famously stoic about pain — behavioral signs of joint pain (reduced jumping, stiffness, reduced grooming, behavioral changes) should be evaluated by a veterinarian before assuming CBDalone is managing the condition.
Excessive sedation and lethargy (most common at too-high dose); ataxia or stumbling; vomiting; reduced appetite; head shaking or lip-licking (often taste-related rather than toxicity). For any severe symptoms — tremors, seizures, extreme agitation — contact your veterinarian or ASPCA Animal Poison Control (1-888-426-4435) immediately.
CBD may offer meaningful support for anxious or painful cats — the ECS mechanisms are present and the limited research is cautiously encouraging. But cats require a uniquely careful approach that starts with product selection. The wrong ingredients — not too much CBD — are the primary safety risk for cats.
Zero THC, zero essential oils, zero propylene glycol, zero xylitol. Cat-appropriate concentration for precise small-dose measurement. Veterinary consultation before starting. Conservative dosing starting at 0.1mg/kg. Slow titration with careful observation.
The gap between dog CBD evidence and cat CBD evidence is significant — three academic RCTs for dogs, zero for cats. This doesn't mean CBD can't help cats; it means the evidence-based confidence is lower, and the safety caution needs to be proportionally higher. When in doubt, discuss with your veterinarian before starting any supplement for your cat.
Veterinary Safety Notice | This article is for informational and educational purposes only and does not constitute veterinary advice. Cats have unique metabolic vulnerabilities that make many human and dog CBD products potentially toxic. Always consult a licensed veterinarian before giving CBD to your cat. Verify that any product given to cats is free of THC, essential oils, propylene glycol, and xylitol. For toxicity emergencies: ASPCA Animal Poison Control 1-888-426-4435. CBD is not FDA-approved for veterinary use. Individual results may vary.
Medical Disclaimer | Sauna use is contraindicated in certain cardiovascular conditions, pregnancy, and with medications that impair heat tolerance...
Read More
Medical Disclaimer | Cold water immersion is contraindicated in people with cardiovascular conditions, Raynaud's disease, hypertension, or cold ur...
Read More
Medical Disclaimer | This article is for informational and educational purposes only. Intermittent fasting and CBD supplementation should be appro...
Read More